Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Cazzola

Showing results (481-490 of 645) with videos related to

Pageof 65
Sort By:
American Journal of Hematology|September 29, 2011
Identification of genomic aberrations associated with disease transformation by means of high-resolution SNP array analysis in patients with myeloproliferative neoplasmElisa Rumi, Ashot Harutyunyan, Chiara Elena, et al.
Respiratory Medicine|June 23, 2019
Long-term observational study on the impact of GLP-1R agonists on lung function in diabetic patientsPaola Rogliani, Maria Gabriella Matera, Luigino Calzetta, et al.
Leukemia & Lymphoma|November 30, 2016
Vascular endothelial growth factor overexpression in myelodysplastic syndrome bone marrow cells: biological and clinical implicationsRosangela Invernizzi, Erica Travaglino, Matteo Giovanni Della Porta, et al.
British Journal of Haematology|March 12, 2002
Pipobroman is safe and effective treatment for patients with essential thrombocythaemia at high risk of thrombosisFrancesco Passamonti, Lucia Malabarba, Ester Orlandi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2008
Erythropoietin and granulocyte-colony stimulating factor treatment associated with improved survival in myelodysplastic syndromeMartin Jädersten, Luca Malcovati, Ingunn Dybedal, et al.
Blood|November 7, 2007
Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disordersDaniela Pietra, Sai Li, Angela Brisci, et al.
Blood|April 13, 2016
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemiaDaniel A Arber, Attilio Orazi, Robert Hasserjian, et al.
Cancer|September 26, 2006
JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disordersElisa Rumi, Francesco Passamonti, Daniela Pietra, et al.
Cancer|July 28, 2005
Leukemic transformation of polycythemia vera: a single center study of 23 patientsFrancesco Passamonti, Elisa Rumi, Luca Arcaini, et al.
Leukemia & Lymphoma|February 28, 2013
Clues to pathogenesis of Waldenström macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance provided by analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptorsMarzia Varettoni, Silvia Zibellini, Daniela Capello, et al.
Pageof 65

Showing results (481-490 of 645) with videos related to

Sort By:
Pageof 65
American Journal of Hematology|September 29, 2011
Identification of genomic aberrations associated with disease transformation by means of high-resolution SNP array analysis in patients with myeloproliferative neoplasmElisa Rumi, Ashot Harutyunyan, Chiara Elena, et al.
Respiratory Medicine|June 23, 2019
Long-term observational study on the impact of GLP-1R agonists on lung function in diabetic patientsPaola Rogliani, Maria Gabriella Matera, Luigino Calzetta, et al.
Leukemia & Lymphoma|November 30, 2016
Vascular endothelial growth factor overexpression in myelodysplastic syndrome bone marrow cells: biological and clinical implicationsRosangela Invernizzi, Erica Travaglino, Matteo Giovanni Della Porta, et al.
British Journal of Haematology|March 12, 2002
Pipobroman is safe and effective treatment for patients with essential thrombocythaemia at high risk of thrombosisFrancesco Passamonti, Lucia Malabarba, Ester Orlandi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2008
Erythropoietin and granulocyte-colony stimulating factor treatment associated with improved survival in myelodysplastic syndromeMartin Jädersten, Luca Malcovati, Ingunn Dybedal, et al.
Blood|November 7, 2007
Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disordersDaniela Pietra, Sai Li, Angela Brisci, et al.
Blood|April 13, 2016
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemiaDaniel A Arber, Attilio Orazi, Robert Hasserjian, et al.
Cancer|September 26, 2006
JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disordersElisa Rumi, Francesco Passamonti, Daniela Pietra, et al.
Cancer|July 28, 2005
Leukemic transformation of polycythemia vera: a single center study of 23 patientsFrancesco Passamonti, Elisa Rumi, Luca Arcaini, et al.
Leukemia & Lymphoma|February 28, 2013
Clues to pathogenesis of Waldenström macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance provided by analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptorsMarzia Varettoni, Silvia Zibellini, Daniela Capello, et al.
Pageof 65